高风险子宫内膜癌微创手术后复发风险相关因素
本研究为加拿大妇科肿瘤学会社区实践的多中心回顾性队列研究,纳入2012至2016年间8个中心接受微创手术的758例高级别子宫内膜癌患者。中位随访30.5个月,复发157例(20.71%),其中腹腔内复发92例(12.14%)。多因素分析显示仅分期和标本重量>75百分位与腹腔内复发风险独立相关(OR 2.207,CI 1.123-4.337)。
要点
- 高级别子宫内膜癌微创手术后腹腔内复发率为12.14%。
- 标本重量>75百分位与腹腔内复发风险独立相关(OR 2.207)。
- 子宫体积和重量与腹腔外复发风险无关。
核心结论
- 对于接受微创手术的高级别子宫内膜癌患者,取出大子宫与腹腔内复发风险显著增加相关。
研究设计与样本
- 回顾性队列研究,纳入2012至2016年间加拿大8个中心接受微创手术的758例高级别子宫内膜癌患者。
主要发现
- 中位随访30.5个月(四分位距20-47),复发157例(20.71%),其中腹腔内复发92例(12.14%),仅腹腔外复发60例(7.92%)。
- 单因素分析中,肌层浸润、淋巴血管间隙浸润、分期、子宫体积和重量>75百分位以及化疗与腹腔内复发风险增加相关。
- 多因素分析中,仅分期和标本重量>75百分位(OR 2.207,CI 1.123-4.337)保持显著。
- 子宫体积和重量与腹腔外复发风险增加无关。
临床怎么用
- 对高级别子宫内膜癌患者行微创手术时,需关注大子宫取出相关的腹腔内复发风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Minimally invasive surgery (MIS) is a standard surgical approach for comprehensive surgical staging in women with endometrial cancer. As rates and complexity of MIS are steadily increasing, it is important to identify potential risk factors which may be associated with this approach. This study evaluates the impact of local factors on the risk of disease recurrence. METHODS: A retrospective cohort study was conducted of patients diagnosed with high grade endometrial cancer (HGEC) who underwent MIS between 2012 and 2016 at eight Canadian centers. Data was collected from medical records. The 75th percentile was calculated for estimated uterine volume and weight. All recurrences were categorized into two groups; intra-abdominal vs. extra-abdominal. To search for significant covariates associated with recurrence-free survival a Cox proportional hazard model was performed. RESULTS: A total of 758 patients were included in the study. Intra-uterine manipulator was used in 497 (35.8%) of patients. Vaginal lacerations were documented in 9.1%. Median follow-up was 30.5 months (interquartile range 20-47). There were 157 who had disease recurrence (20.71%), including 92 (12.14%) intra-abdominal and 60 (7.92%) extra-abdominal only recurrences. In univariate analysis myometrial invasion, LVI, stage, uterine volume and weight > 75th percentile and chemotherapy were associated with increased risk of intra-abdominal recurrence. In multivariable analysis only stage, and specimen weight > 75th percentile (OR 2.207, CI 1.123-4.337) remained significant. Uterine volume, and weight were not associated with increased risk of extra-abdominal recurrences. CONCLUSION: For patients diagnosed with HGEC undergoing MIS, extracting a large uterus is associated with a significantly increased risk for intra-abdominal recurrence.
引用
- Feigenberg T, Cormier B, Gotlieb WH, et al. Factors associated with an increased risk of recurrence in patients diagnosed with high-grade endometrial cancer undergoing minimally invasive surgery: A study of the society of gynecologic oncology of Canada (GOC) community of practice (CoP). Gynecol Oncol. 2021. PMID: 34183164. doi:10.1016/j.ygyno.2021.06.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。